Vendor Neutral Archive (VNA) & PACS Market: Growth, Size, Share, and Trends

Report Code HIT 2128
Published in May, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-site), Modality (CT, MRI, X-ray, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag Center) & Region - Global Forecast to 2030

Overview

The global vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market, valued at US$4.62 billion in 2024, stood at US$5.10 billion in 2025 and is projected to advance at a resilient CAGR of 9.2% from 2025 to 2030, culminating in a forecasted valuation of US$7.92 billion by the end of the period. The growth in the medical imaging sector is predominantly fueled by the escalating volume of imaging data and a stronger regulatory push for EHR implementation. Additionally, the ongoing transition towards value-based care is prompting increased investments in scalable and interoperable imaging solutions. Key technological advancements, such as cloud-based storage, AI, and analytics integration, are significantly driving the adoption of VNA and PACS; these innovations facilitate improved clinical workflows, enhance data accessibility, and ultimately lead to better patient care outcomes.

Vendor Neutral Archive (VNA) & PACS Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Vendor Neutral Archive (VNA) & PACS Market

North America

North America offers significant growth potential, driven by the widespread adoption of advanced imaging technologies, the increasing digitalization of healthcare systems, and the rising demand for interoperable and scalable data management platforms.

Factors such as growing imaging volumes, the push for integrated healthcare IT systems, and the need for efficient image sharing across healthcare networks accelerate the adoption of VNA and PACS across the region.

Strategic partnerships, cloud-based solution launches, and multi-site VNA deployments are expected to create strong market opportunities for both established players and new entrants over the next five years.

The North American VNA & PACS market is projected to grow at a significant CAGR, supported by rising investments in enterprise imaging infrastructure.

The region’s strong healthcare IT infrastructure, high per capita health expenditure, and increased government efforts to promote interoperability and patient data security continue to fuel the demand for next-generation archiving and communication solutions.

Global Vendor Neutral Archive (VNA) & PACS Market Dynamics

DRIVER: Increasing investments in medical imaging technologies

Electronic health record (EHR) systems serve as centralized digital repositories that aggregate comprehensive patient data, from medical histories to diagnostic results, enhancing the accessibility and collaboration among healthcare providers. This integration streamlines clinical workflows, minimizes duplicative efforts, and empowers data-driven decision-making, thereby significantly optimizing patient outcomes. In the contemporary healthcare landscape, the implementation of EHRs is pivotal. As of 2021, about 96% of non-federal acute care hospitals and 78% of office-based physicians in the US had adopted certified EHR systems, underscoring their critical role in advancing healthcare delivery; this trend mirrors a global initiative to digitize health records, aimed at improving operational efficiency and care quality.

Furthermore, EHR integration promotes interoperability across various health information technology systems, facilitating the synthesis and analysis of data from multiple sources, including pharmacy systems, laboratory information systems, and public health registries. This interconnected framework helps deliver comprehensive patient care, allowing for real-time data exchange and collaboration among multidisciplinary teams. Additionally, integrated EHRs enhance public health efforts by providing crucial data for disease surveillance and population health research initiatives, showcasing their broader impact beyond individual patient encounters.

RESTRAINT: Increasing data security and privacy concerns

The escalating digitization of medical imaging data has intensified concerns regarding data security and patient privacy, serving as a significant barrier to the widespread adoption of VNA and PACS solutions. Given the sensitive nature of the data handled by healthcare organizations, these entities are increasingly targeted by cyber threats. As reported by the HIPAA Journal, the healthcare sector witnessed a staggering 725 large-scale data breaches in 2023, compromising over 133 million patient records; this statistic underscores a marked increase in vulnerability compared to previous years, highlighting the urgent need for enhanced data protection strategies. The financial ramifications of these breaches are considerable. The HIPAA Journal cites that the average cost of a healthcare data breach in 2023 reached nearly USD 11 million, surpassing the average for all other industries. These costs not only cover immediate remedial expenses but also extend to long-term effects, including regulatory penalties, legal expenditures, and damage to institutional reputation. To address these cybersecurity challenges, healthcare organizations must deploy comprehensive security measures. This includes implementing data encryption protocols, enforcing multi-factor authentication, and conducting regular security audits. Adherence to compliance frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) is also essential for safeguarding sensitive health information and maintaining trust in healthcare data systems.

 

OPPORTUNITY: Increasing medical imaging procedures and large imaging data silos

The increasing volume of medical imaging procedures has led to a significant rise in the demand for VNA and PACS solutions. These advanced systems provide scalable and efficient methods for managing vast amounts of imaging data, enabling healthcare providers to centralize medical images and their associated metadata into a standardized format. This standardization is crucial as it dismantles existing data silos, facilitating seamless interoperability across various systems and departments within healthcare organizations. The advancement and integration of artificial intelligence (AI) and data analytics into VNA and PACS solutions have brought about a transformative shift in the healthcare landscape. These technologies allow for automated image analysis, enabling healthcare professionals to quickly identify patterns and anomalies in medical images with greater accuracy. Predictive analytics tools use historical data to forecast potential health issues, assisting clinicians in making proactive decisions about patient care. Furthermore, clinical decision support systems leverage AI to provide evidence-based recommendations to healthcare providers, thereby enhancing diagnostic accuracy and streamlining clinical workflows. Additionally, the application of natural language processing (NLP) plays a vital role in improving workflow efficiency within medical settings. By interpreting and organizing unstructured clinical data, NLP allows healthcare professionals to access and utilize critical information more effectively, refining diagnostic precision and decreasing the time spent on administrative tasks. As AI, NLP, and advanced analytics continue to evolve, VNA and PACS systems are becoming increasingly integral to optimizing healthcare processes. They contribute not only to improved clinical outcomes but also actively drive the future of precision medicine and integrated care. This evolution positions healthcare to better meet the complexities of patient needs, ultimately leading to enhanced quality of care and better health management across populations.

CHALLENGES: Rising security concerns related to cloud-based image processing and analytics

Cloud computing offers numerous advantages, but its implementation in medical imaging and healthcare data management introduces significant security challenges. The consolidation of sensitive information, including personal health records and diagnostic imaging data, within cloud infrastructures raises critical issues regarding data integrity, availability, privacy, and confidentiality. Cloud service providers (CSPs) are responsible for securing vast amounts of highly sensitive data; however, they must navigate persistent risks such as data breaches, unauthorized access, data theft, and potential service downtime. Consequently, many healthcare organizations are cautious about migrating confidential medical data to the cloud, primarily due to concerns about relinquishing direct control over their information security. Outsourcing data to third-party cloud data centers means that healthcare providers depend on CSP’s security protocols and infrastructure. While CSPs employ various protective measures—ranging from firewalls and encryption to advanced virtualization technologies—these solutions do not ensure foolproof protection against sophisticated cyber threats or inadvertent human errors. Therefore, a careful assessment of the risk-benefit balance is essential for healthcare entities considering cloud adoption.

Global Vendor Neutral Archive (VNA) & PACS Market Ecosystem Analysis

The VNA & PACS market is highly competitive and involves a wide range of intermediaries. Stakeholders in the medical imaging sector operate within a rapidly evolving landscape, significantly influenced by technological advancements and changing healthcare priorities. Key players include VNA and PACS vendors, which range from large corporations to niche specialists, all dedicated to providing cutting-edge solutions for managing and storing imaging data. These vendors are required to navigate complex regulatory frameworks established by agencies such as the FDA, EMA, and Health Canada. These regulations impose strict compliance demands concerning data security, interoperability standards, and patient privacy protections. Moreover, governmental organizations such as the Department of Health and Human Services (HHS) and the National Health Service (NHS) play a critical role in shaping market dynamics through strategic policy-making, funding programs, and regulatory oversight. End users—including hospitals & clinics, ambulatory surgery centers, and diagnostic centers—drive the adoption of VNA and PACS technologies, seeking to enhance workflow efficiency, improve diagnostic precision, and elevate patient care outcomes.

Vendor Neutral Archive (VNA) & PACS Market Ecosystem
 

The VNA segment held the largest market share, by product type, in 2024.

In 2024, the VNA segment held the largest share of the VNA & PACS market due to its capability to provide a centralized repository for storing medical images and related metadata in a standardized format, independent of specific imaging modalities or vendors. VNA enables efficient interoperability for data exchange across diverse systems and healthcare facilities, thereby enhancing collaboration and care coordination among providers. The VNA landscape can be delineated into three categories: departmental, multi-department, and multi-site VNA, each tailored to address the specific requirements of various levels within healthcare organizations. These solutions are essential for handling substantial volumes of imaging data, ensuring that medical images are readily accessible across multiple departments, locations, and systems; this access not only streamlines operational workflows but also optimizes patient care delivery. As the healthcare sector increasingly adopts value-based care models, the significance of comprehensive data management solutions, such as VNA, has escalated. Furthermore, VNA empowers healthcare organizations to leverage medical imaging data for initiatives related to population health management, predictive analytics, and personalized medicine. This strategic positioning has established VNA solutions as pivotal contributors to the evolving landscape of medical imaging and healthcare informatics.

By deployment model, the cloud-based deployment segment is projected to have the highest CAGR during the forecast period.

The VNA & PACS market is segmented by deployment into cloud-based, on-premises, and hybrid deployment. The cloud-based segment is poised for robust growth throughout the forecast period, driven by a multitude of advantageous factors. Cloud-based VNA and PACS solutions eliminate the necessity for substantial investments in on-premises infrastructure, allowing healthcare organizations to leverage scalable storage and computing resources that can be dynamically configured according to fluctuating demand. This adaptability is particularly critical as healthcare entities grapple with the surging volumes of medical imaging data generated from diagnostic modalities such as X-rays, MRIs, and CT scans.

Cloud service providers (CSPs) employ comprehensive security measures—including encryption, stringent access controls, and periodic security audits—to ensure the integrity and confidentiality of patient data. These protocols are essential for meeting regulatory compliance standards such as HIPAA and GDPR, mitigating the risks associated with potential data breaches, which are a major concern for healthcare organizations managing sensitive medical information. In addition, the cost-efficiency of cloud deployment models presents a compelling incentive for organizations aiming to curtail capital expenditures on physical infrastructure while capitalizing on the inherent flexibility of cloud storage solutions. The benefits of remote access and real-time monitoring afforded by cloud-based systems facilitate enhanced collaboration among healthcare professionals, enabling seamless access to imaging data across geographically dispersed locations while ensuring the health and security of the data remain intact.

North America accounted for the largest share of the VNA & PACS market in 2024.

In 2024, North America holds the predominant share of the VNA & PACS market. The region is witnessing a rapid expansion in cloud-based VNA and PACS solutions, driven by a significant shift towards digital health and an increasing demand for scalable and flexible storage architectures. Healthcare providers across the US and Canada are increasingly integrating cloud-based systems to efficiently manage the escalating volumes of medical imaging data, thereby facilitating improved collaboration and expedited access to diagnostic images across distributed healthcare environments. This trend is also influenced by the regulatory landscape, particularly HIPAA compliance requirements, and the broader shift towards value-based healthcare models. Cloud-based architecture offers a cost-effective alternative to traditional on-premises solutions, while also incorporating robust security protocols such as encryption and granular access controls to safeguard sensitive patient information.

LARGEST MARKET SIZE IN 2024
US: FASTEST-GROWING MARKET IN REGION
Vendor Neutral Archive (VNA) & PACS Market Region

Recent Developments of Vendor Neutral Archive (VNA) & PACS Market

  • In April 2025, Siemens Healthineers (Germany) and Tower Health (US) unveiled a 10-year value partnership to upgrade imaging systems and digital tools and enhance diagnostic capabilities.
  • In March 2025, GE Healthcare (US) launched the Genesis Cloud Suite, an enterprise imaging SaaS portfolio offering edge, storage, VNA, and data migration solutions to improve workflow efficiency, precision, and IT resource optimization for healthcare providers.
  • In March 2025, FUJIFILM Healthcare Americas (US) partnered with AWS (US) to enhance digital pathology and cloud integration to streamline data lifecycle management and optimize storage of large pathology files within Fujifilm’s Synapse Pathology platform.
  • In November 2024, Canon Medical Systems Corporation (Japan) partnered with Penn Medicine to advance photon-counting CT (PCCT) technology, following the installation of Canon's fourth global PCCT system at the Hospital of the University of Pennsylvania, aiming to enhance diagnostic capabilities through clinical feedback.

Key Market Players

Scope of the Report

Report Metric Details
Market size available for years 2023-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Million/Billion (USD)
Segments covered Product Type, Modality, Deployment, Vendor Type, Application, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Frequently Asked Questions(FAQ)

Which are the top industry players in the global Vendor Neutral Archive (VNA) & PACS market?

Prominent players in the VNA & PACS market include Hyland Software, Inc. (US), Agfa-Gevaert Group (Belgium), Intelerad Medical Systems Inc. (Canada), Canon Medical Systems Corporation (Japan), FUJIFILM Holdings Corporation (Japan), GE Healthcare (US), Merative (US), Sectra AB (Sweden), Siemens Healthcare Limited (Germany), BridgeHead Software Ltd. (UK), Canopy Partners. (US), Novarad Corporation (US), POSTDICOM (Netherlands), AdvaHealth Solutions Pte Ltd. (Singapore), CrelioHealth (India), Medicasoft (US), Esaote SPA (Italy), PaxeraHealth (US), VISUS Health IT GmbH (Germany), ASPYRA, LLC (US), Dedalus S.p.A. (Italy), SoftTeam Solutions Pvt. Ltd. (India), ARO Systems (Australia), Central Data Networks (Australia), and ONEPACS (US).

Which products & services have been included in the Vendor Neutral Archive (VNA) & PACS market report?

This report contains the following Vendor Neutral Archive (VNA) & PACS products

  • VNA
    • Department VNA
    • Multi-department VNA
    • Multi-site VNA
  • PACS
    • Department PACS
    • Multi-department PACS
    • Multi-site PACS

 

Which geographical region dominates in the global VNA & PACS market?

The VNA & PACS market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share, and the Asia Pacific registers the highest growth rate in the VNA & PACS market.

Which end-user segments have been included in the VNA & PACS market report?

The report contains the following application segments:\

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Other End Users

 

What is the total CAGR expected to be recorded for the VNA & PACS market from 2025 to 2030?

The CAGR is expected to record a CAGR of 9.2% from 2025 to 2030

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Vendor Neutral Archive (VNA) & PACS Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
27
RESEARCH METHODOLOGY
32
EXECUTIVE SUMMARY
48
PREMIUM INSIGHTS
53
MARKET OVERVIEW
57
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Heightened investments in medical imaging technologies
    - Growing demand for streamlined healthcare data management solutions
    - Integration of PACS/VNA with electronic medical records
    RESTRAINTS
    - High initial investment for implementing VNA and PACS solutions
    - Lack of standardized protocols and interoperability frameworks
    OPPORTUNITIES
    - Favorable government initiatives for better penetration of Al in medical imaging
    - Increasing medical imaging procedures and large imaging data silos
    - Rapid uptake of big data in healthcare
    CHALLENGES
    - Rising security concerns related to cloud-based image processing and analytics
    - Data security issues in healthcare settings
  • 5.3 INDUSTRY TRENDS
    CLOUD ADOPTION
    AI AND ML INTEGRATION
    VALUE-BASED CARE MODELS
  • 5.4 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Digital imaging and communications in medicine (DICOM)
    - Enterprise imaging solutions
    - Cloud-based storage and services
    COMPLEMENTARY TECHNOLOGIES
    - Image exchange networks
    - Data analytics and business intelligence
    ADJACENT TECHNOLOGIES
    - Health information exchange (HIE)
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    ROLE IN ECOSYSTEM
  • 5.8 INVESTMENT & FUNDING SCENARIO
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    INTENSITY OF COMPETITIVE RIVALRY
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.12 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY PRODUCT TYPE, 2024
    AVERAGE SELLING PRICE OF VNA & PACS SOLUTIONS, BY REGION (QUALITATIVE)
  • 5.13 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
  • 5.14 PATENT ANALYSIS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    LIST OF MAJOR PATENTS, 2020–2024
  • 5.15 CASE STUDY ANALYSIS
    AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
    NHS TRUST ADOPTED INSTANT DATA ACCESS VNA TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • 5.16 UNMET NEEDS & END-USER EXPECTATIONS
    UNMET NEEDS
    END-USER EXPECTATIONS
  • 5.17 BUSINESS MODELS
    ENTERPRISE LICENSING MODELS
    SOFTWARE-AS-A-SERVICE (SAAS) MODELS
    PAY-PER-USE MODELS
    HYBRID MODELS
  • 5.18 IMPACT OF 2025 US TARIFF ON VNA & PACS MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - North America
    - Europe
    - Asia Pacific
    IMPACT ON END-USE INDUSTRIES
    - Hospitals & clinics
    - Diagnostics centers
    - Ambulatory surgery centers
    - Other end users
    CONCLUSION
VNA & PACS MARKET, BY MODALITY
88
  • 6.1 INTRODUCTION
  • 6.2 CT
    GROWING NEED FOR IMAGING MODALITIES IN MEDICAL FIELDS TO SUPPORT MARKET GROWTH
  • 6.3 MAMMOGRAPHY
    RISING INCIDENCE OF BREAST CANCER TO PROPEL MARKET GROWTH
  • 6.4 ULTRASOUND
    TECHNOLOGICAL ADVANCEMENTS IN ULTRASOUND DEVICES TO AID MARKET GROWTH
  • 6.5 MRI
    COST-EFFECTIVENESS AND EASY AVAILABILITY IN SMALL HEALTHCARE FACILITIES TO FUEL MARKET ADOPTION
  • 6.6 X-RAY
    DEVELOPMENTS IN X-RAY IMAGING TO BOOST ADOPTION OF VNA AND PACS SOLUTIONS
  • 6.7 PET
    NEED FOR BETTER MANAGEMENT AND STORAGE OF LARGE DATA VOLUMES TO FAVOR MARKET GROWTH
VNA & PACS MARKET, BY DEPLOYMENT MODEL
97
  • 7.1 INTRODUCTION
  • 7.2 ON-PREMISES DEPLOYMENT MODELS
    BETTER CONTROL AND SECURITY FOR SENSITIVE PATIENT DATA TO AUGMENT MARKET GROWTH
  • 7.3 CLOUD-BASED DEPLOYMENT MODELS
    TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING MODALITIES TO DRIVE MARKET
  • 7.4 HYBRID DEPLOYMENT MODELS
    GREATER FLEXIBILITY, SCALABILITY, AND CONTROL OVER DATA MANAGEMENT STRATEGIES TO PROPEL MARKET GROWTH
VNA & PACS MARKET, BY PRODUCT TYPE
103
  • 8.1 INTRODUCTION
  • 8.2 VNA
    DEPARTMENT VNA
    - Limitations in addressing scalability and interoperability across diverse departments to hinder market growth
    MULTI-DEPARTMENT VNA
    - Multi-department VNA to streamline data management processes and reduce redundancies
    MULTI-SITE VNA
    - Multi-site VNA to provide centralized repository for managing medical data and standardizing medical records
  • 8.3 PACS
    DEPARTMENT PACS
    - Need for better medical imaging data storage to aid market growth
    MULTI-DEPARTMENT PACS
    - Technological advancements in multi-department PACS to improve image retrieval speed and ensure data integrity
    MULTI-SITE PACS
    - Advancements in cloud-based PACS solutions to propel market growth
VNA & PACS MARKET, BY VENDOR TYPE
113
  • 9.1 INTRODUCTION
  • 9.2 INDEPENDENT VENDORS
    INCREASED FLEXIBILITY, BETTER INTEROPERABILITY, AND IMPROVED SOLUTIONS TO DRIVE MARKET
  • 9.3 THIRD-PARTY VENDORS
    NEED FOR INNOVATIVE SOLUTIONS TO DRIVE THIRD-PARTY VENDOR PRESENCE
VNA & PACS MARKET, BY APPLICATION
118
  • 10.1 INTRODUCTION
  • 10.2 CARDIOLOGY
    RISING CASES OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
  • 10.3 ORTHOPEDIC
    GROWING VOLUME AND COMPLEXITY OF ORTHOPEDIC MEDICAL IMAGING SCANS TO PROPEL MARKET GROWTH
  • 10.4 ONCOLOGY
    RISING NUMBER OF CANCER CASES TO DRIVE USE OF VNA AND PACS SOLUTIONS FOR ONCOLOGY
  • 10.5 NEUROLOGY
    INCREASING DEMAND FOR ADVANCED NEUROLOGICAL IMAGING TECHNOLOGIES TO SPUR GROWTH
  • 10.6 OBSTETRICS & GYNECOLOGY
    USE OF 3D AND 4D IMAGING FOR MONITORING FETUS GROWTH AND DIAGNOSING HIGH-RISK PREGNANCIES TO DRIVE MARKET
  • 10.7 OTHER APPLICATIONS
VNA & PACS MARKET, BY END USER
126
  • 11.1 INTRODUCTION
  • 11.2 HOSPITALS & CLINICS
    NEED TO IMPROVE PROFITABILITY OF HEALTHCARE SERVICES TO DRIVE USE OF HCIT IN HOSPITALS
  • 11.3 DIAGNOSTIC CENTERS
    LACK OF ADVANCED IMAGING MODALITIES IN SMALL AND MID-SCALE HOSPITALS TO AUGMENT MARKET GROWTH
  • 11.4 AMBULATORY SURGERY CENTERS
    INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH
  • 11.5 OTHER END USERS
VNA & PACS MARKET, BY REGION
132
  • 12.1 INTRODUCTION
  • 12.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate global VNA & PACS market during study period
    CANADA
    - Rising cases of end-stage kidney diseases to propel market growth
  • 12.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing number of MRI units and diagnostic imaging centers to drive market
    UK
    - Rising funding and investments in diagnostic imaging to support market growth
    FRANCE
    - Rising target patient population and increasing government-funded investments to fuel uptake of VNA and PACS solutions
    ITALY
    - Established healthcare infrastructure to aid market growth
    SPAIN
    - Growing access to advanced cancer diagnostics to propel market
    REST OF EUROPE
  • 12.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Presence of universal healthcare coverage to fuel market
    CHINA
    - Strong government support for healthcare reforms and increased number of medical imaging procedures to drive market
    INDIA
    - Improving healthcare infrastructure and increasing private-public partnerships to support market growth
    REST OF ASIA PACIFIC
  • 12.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Presence of free and universal healthcare system to propel market growth
    MEXICO
    - Rapid technological advancements in imaging solutions to support market growth
    REST OF LATIN AMERICA
  • 12.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Technological integration to spur inclusivity, accessibility, affordability, and growth in healthcare sector
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
211
  • 13.1 INTRODUCTION
  • 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VNA & PACS MARKET
  • 13.3 REVENUE ANALYSIS, 2020–2024
  • 13.4 MARKET SHARE ANALYSIS, 2024
  • 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product type footprint
    - Deployment model footprint
    - End-user footprint
  • 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SME players
    - Competitive benchmarking of startups/SME players
  • 13.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 13.8 BRAND/SOFTWARE COMPARISON
  • 13.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
232
  • 14.1 KEY COMPANIES
    AGFA-GEVAERT GROUP
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    SECTRA AB
    - Business overview
    - Solutions offered
    - MnM view
    GE HEALTHCARE
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    MERATIVE
    - Business overview
    - Solutions offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Solutions offered
    - Recent developments
    CANON MEDICAL SYSTEMS CORPORATION
    - Business overview
    - Solutions offered
    - Recent developments
    INTELERAD. INTELERAD.
    - Business overview
    - Solutions offered
    - Recent developments
    PAXERAHEALTH
    - Business overview
    - Solutions offered
    NOVARAD CORPORATION
    - Business overview
    - Solutions offered
    HYLAND SOFTWARE, INC.
    - Business overview
    - Solutions offered
    - Recent developments
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Solutions offered
    - Recent developments
    BRIDGEHEAD SOFTWARE LTD.
    - Business overview
    - Solutions offered
    - Recent developments
    CANOPY PARTNERS
    - Business overview
    - Solutions offered
    CRELIOHEALTH INC.
    - Business overview
    - Solutions offered
    ASPYRA, LLC
    - Business overview
    - Solutions offered
    POSTDICOM
    - Business overview
    - Solutions offered
    MEDICASOFT
    - Business overview
    - Solutions offered
    ESAOTE S.P.A.
    - Business overview
    - Solutions offered
    - Recent developments
    VISUS HEALTH IT GMBH
    - Business overview
    - Solutions offered
  • 14.2 OTHER PLAYERS
    ADVAHEALTH SOLUTIONS
    SOFTTEAM SOLUTIONS PVT. LTD.
    ARO SYSTEMS
    CENTRAL DATA NETWORKS
    ONEPACS
    DEDALUS S.P.A.
APPENDIX
279
  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 VNA & PACS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 VNA & PACS MARKET: FACTOR ANALYSIS
  • TABLE 3 VNA & PACS MARKET: STUDY ASSUMPTIONS
  • TABLE 4 VNA & PACS MARKET: RISK ANALYSIS
  • TABLE 5 VNA & PACS MARKET: ROLE IN ECOSYSTEM
  • TABLE 6 VNA & PACS MARKET: PORTER’S FIVE FORCES
  • TABLE 7 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • TABLE 8 KEY BUYING CRITERIA FOR MAJOR END USERS
  • TABLE 9 VNA & PACS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 10 AVERAGE SELLING PRICE OF PACS SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 11 AVERAGE SELLING PRICE OF VNA SOLUTIONS, BY PRODUCT TYPE, 2024
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR VNA & PACS SOLUTIONS
  • TABLE 17 VNA & PACS MARKET: LIST OF PATENTS/PATENT APPLICATIONS, 2020–2024
  • TABLE 18 CASE STUDY 1: AMBRA HEALTH UTILIZED AWS CLOUD SERVICES TO PROPEL MEDICAL IMAGING PLATFORM GROWTH
  • TABLE 19 CASE STUDY 2: NHS TRUST ADOPTED INSTANT DATA ACCESS TO ESTABLISH UNIFIED PLATFORM FOR DICOM IMAGE DATA STORAGE AND MANAGEMENT
  • TABLE 20 VNA & PACS MARKET: UNMET NEEDS
  • TABLE 21 VNA & PACS MARKET: END-USER EXPECTATIONS
  • TABLE 22 VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 23 VNA & PACS MARKET FOR CT, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 24 VNA & PACS MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 25 VNA & PACS MARKET FOR ULTRASOUND, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 26 VNA & PACS MARKET FOR MRI, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 VNA & PACS MARKET FOR X-RAY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 28 VNA & PACS MARKET FOR PET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 30 VNA & PACS MARKET FOR ON-PREMISES DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 VNA & PACS MARKET FOR CLOUD-BASED DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 VNA & PACS MARKET FOR HYBRID DEPLOYMENT MODELS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 34 VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 35 VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 DEPARTMENT VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 MULTI-DEPARTMENT VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 MULTI-SITE VNA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 40 PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 DEPARTMENT PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 MULTI-DEPARTMENT PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 MULTI-SITE PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 45 KEY INDEPENDENT VENDORS OPERATING IN MARKET
  • TABLE 46 VNA & PACS MARKET FOR INDEPENDENT VENDORS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 KEY THIRD-PARTY VENDORS OPERATING IN MARKET
  • TABLE 48 VNA & PACS MARKET FOR THIRD-PARTY VENDORS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 50 VNA & PACS MARKET FOR CARDIOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 VNA & PACS MARKET FOR ORTHOPEDIC, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 VNA & PACS MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 VNA & PACS MARKET FOR NEUROLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 VNA & PACS MARKET FOR OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 VNA & PACS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 56 VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 57 VNA & PACS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 VNA & PACS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 VNA & PACS MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 VNA & PACS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 VNA & PACS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 71 US: KEY MACROINDICATORS
  • TABLE 72 US: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 73 US: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 74 US: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 75 US: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 76 US: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 77 US: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 78 US: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 79 US: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 80 CANADA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 81 CANADA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 82 CANADA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 83 CANADA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 84 CANADA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 85 CANADA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 86 CANADA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 87 CANADA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 88 EUROPE: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 90 EUROPE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 91 EUROPE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 92 EUROPE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 93 EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 94 EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 95 EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 96 EUROPE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 97 GERMANY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 GERMANY: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 99 GERMANY: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 GERMANY: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 101 GERMANY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 102 GERMANY: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 103 GERMANY: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 104 GERMANY: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 105 UK: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 UK: VNA MARKET, BY TYPE 2023–2030 (USD MILLION)
  • TABLE 107 UK: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 UK: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 109 UK: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 110 UK: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 111 UK: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 112 UK: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 113 FRANCE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 FRANCE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 115 FRANCE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 116 FRANCE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 117 FRANCE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 118 FRANCE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 FRANCE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 120 FRANCE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 121 ITALY: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 122 ITALY: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 123 ITALY: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 124 ITALY: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 125 ITALY: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 126 ITALY: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 127 ITALY: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 128 ITALY: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 129 SPAIN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 130 SPAIN: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 131 SPAIN: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 SPAIN: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 133 SPAIN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 134 SPAIN: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 SPAIN: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 136 SPAIN: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE,2023–2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 154 JAPAN: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 JAPAN: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 JAPAN: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 157 JAPAN: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 158 JAPAN: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 159 JAPAN: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 JAPAN: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 161 JAPAN: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 162 CHINA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 163 CHINA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 CHINA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 165 CHINA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 166 CHINA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 167 CHINA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 CHINA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 169 CHINA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 170 INDIA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 INDIA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 INDIA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 INDIA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 174 INDIA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 175 INDIA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 INDIA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 177 INDIA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 178 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 179 REST OF ASIA PACIFIC: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 REST OF ASIA PACIFIC: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 182 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 183 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 186 LATIN AMERICA: VNA & PACS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 187 LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 LATIN AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 LATIN AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 191 LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 192 LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 194 LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 195 BRAZIL: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 BRAZIL: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 BRAZIL: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 BRAZIL: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 199 BRAZIL: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 200 BRAZIL: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 201 BRAZIL: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 202 BRAZIL: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 203 MEXICO: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 MEXICO: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 MEXICO: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 MEXICO: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 207 MEXICO: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 208 MEXICO: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 209 MEXICO: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 210 MEXICO: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 211 REST OF LATIN AMERICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 REST OF LATIN AMERICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 213 REST OF LATIN AMERICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 REST OF LATIN AMERICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 215 REST OF LATIN AMERICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 216 REST OF LATIN AMERICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 217 REST OF LATIN AMERICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 218 REST OF LATIN AMERICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 GCC COUNTRIES: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 231 GCC COUNTRIES: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 236 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
  • TABLE 237 REST OF MIDDLE EAST & AFRICA: VNA MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 REST OF MIDDLE EAST & AFRICA: PACS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 239 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY MODALITY, 2023–2030 (USD MILLION)
  • TABLE 240 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2023–2030 (USD MILLION)
  • TABLE 241 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY VENDOR TYPE, 2023–2030 (USD MILLION)
  • TABLE 242 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 243 REST OF MIDDLE EAST & AFRICA: VNA & PACS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 244 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VNA & PACS MARKET, JANUARY 2022–MAY 2025
  • TABLE 245 VNA & PACS MARKET: DEGREE OF COMPETITION
  • TABLE 246 VNA & PACS MARKET: REGION FOOTPRINT
  • TABLE 247 VNA & PACS MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 248 VNA & PACS MARKET: DEPLOYMENT MODEL FOOTPRINT
  • TABLE 249 VNA & PACS MARKET: END-USER FOOTPRINT
  • TABLE 250 VNA & PACS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 251 VNA & PACS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS
  • TABLE 252 VNA & PACS MARKET: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 253 VNA & PACS MARKET: DEALS, JANUARY 2022–MAY 2025
  • TABLE 254 VNA & PACS MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 255 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
  • TABLE 256 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
  • TABLE 257 AGFA-GEVAERT GROUP: DEALS, JANUARY 2022–MAY 2025
  • TABLE 258 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
  • TABLE 259 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
  • TABLE 260 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022–MAY 2025
  • TABLE 261 FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 262 SECTRA AB: COMPANY OVERVIEW
  • TABLE 263 SECTRA AB: SOLUTIONS OFFERED
  • TABLE 264 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 265 GE HEALTHCARE: SOLUTIONS OFFERED
  • TABLE 266 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 267 GE HEALTHCARE: DEALS, JANUARY 2022–MAY 2025
  • TABLE 268 MERATIVE: COMPANY OVERVIEW
  • TABLE 269 MERATIVE: SOLUTIONS OFFERED
  • TABLE 270 MERATIVE: DEALS, JANUARY 2022–MAY 2025
  • TABLE 271 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 272 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
  • TABLE 273 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 274 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 275 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
  • TABLE 276 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
  • TABLE 277 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–MAY 2025
  • TABLE 278 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025
  • TABLE 279 INTELERAD. INTELERAD.: COMPANY OVERVIEW
  • TABLE 280 INTELERAD. INTELERAD.: SOLUTIONS OFFERED
  • TABLE 281 INTELERAD. INTELERAD.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 282 INTELERAD. INTELERAD.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025
  • TABLE 283 PAXERAHEALTH: COMPANY OVERVIEW
  • TABLE 284 PAXERAHEALTH: SOLUTIONS OFFERED
  • TABLE 285 NOVARAD CORPORATION: COMPANY OVERVIEW
  • TABLE 286 NOVARAD CORPORATION: SOLUTIONS OFFERED
  • TABLE 287 HYLAND SOFTWARE, INC.: COMPANY OVERVIEW
  • TABLE 288 HYLAND SOFTWARE, INC.: SOLUTIONS OFFERED
  • TABLE 289 HYLAND SOFTWARE, INC.:DEALS, JANUARY 2022–MAY 2025
  • TABLE 290 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 291 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED
  • TABLE 292 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–MAY 2025
  • TABLE 293 BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW
  • TABLE 294 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
  • TABLE 295 BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2022–MAY 2025
  • TABLE 296 CANOPY PARTNERS: COMPANY OVERVIEW
  • TABLE 297 CANOPY PARTNERS: SOLUTIONS OFFERED
  • TABLE 298 CRELIOHEALTH INC.: COMPANY OVERVIEW
  • TABLE 299 CRELIOHEALTH INC.: SOLUTIONS OFFERED
  • TABLE 300 ASPYRA, LLC: COMPANY OVERVIEW
  • TABLE 301 ASPYRA, LLC: SOLUTIONS OFFERED
  • TABLE 302 POSTDICOM: COMPANY OVERVIEW
  • TABLE 303 POSTDICOM: SOLUTIONS OFFERED
  • TABLE 304 MEDICASOFT: COMPANY OVERVIEW
  • TABLE 305 MEDICASOFT: SOLUTIONS OFFERED
  • TABLE 306 ESAOTE S.P.A.: COMPANY OVERVIEW
  • TABLE 307 ESAOTE S.P.A.: SOLUTIONS OFFERED
  • TABLE 308 ESAOTE S.P.A.: PRODUCT LAUNCHES, JANUARY 2022–MAY 2025
  • TABLE 309 VISUS HEALTH IT GMBH: COMPANY OVERVIEW
  • TABLE 310 VISUS HEALTH IT GMBH: SOLUTIONS OFFERED
  • TABLE 311 ADVAHEALTH SOLUTIONS: COMPANY OVERVIEW
  • TABLE 312 SOFTTEAM SOLUTIONS PVT. LTD.: COMPANY OVERVIEW
  • TABLE 313 ARO SYSTEMS: COMPANY OVERVIEW
  • TABLE 314 CENTRA DATA NETWORKS: COMPANY OVERVIEW
  • TABLE 315 ONEPACS: COMPANY OVERVIEW
  • TABLE 316 DEDALUS S.P.A.: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 VNA & PACS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 VNA & PACS MARKET: YEARS CONSIDERED
  • FIGURE 3 VNA & PACS MARKET: RESEARCH DESIGN
  • FIGURE 4 VNA & PACS MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 VNA & PACS MARKET: PRIMARY SOURCES
  • FIGURE 6 VNA & PACS MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 VNA & PACS MARKET: KEY INSIGHTS FROM PRIMARIES
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 10 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 11 VNA & PACS MARKET: BOTTOM-UP APPROACH
  • FIGURE 12 VNA & PACS MARKET: TOP-DOWN APPROACH
  • FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VNA & PACS MARKET
  • FIGURE 14 VNA & PACS MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
  • FIGURE 15 VNA & PACS MARKET: DATA TRIANGULATION
  • FIGURE 16 VNA & PACS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 VNA & PACS MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 VNA & PACS MARKET, BY DEPLOYMENT MODEL, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 VNA & PACS MARKET, BY VENDOR TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 20 VNA & PACS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 21 VNA & PACS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 22 VNA & PACS MARKET: REGIONAL SNAPSHOT
  • FIGURE 23 NEED TO HANDLE GROWING DATA VOLUME TO FUEL DEMAND FOR VNA AND PACS SOLUTIONS
  • FIGURE 24 JAPAN AND VNA ACCOUNTED FOR SIGNIFICANT MARKET SHARE IN 2024
  • FIGURE 25 CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 26 ASIA PACIFIC TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 28 VNA & PACS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 29 VNA & PACS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • FIGURE 30 VNA & PACS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 31 VNA & PACS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 32 VNA & PACS MARKET: FUNDING AND NUMBER OF DEALS, 2021–2024
  • FIGURE 33 VNA & PACS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MAJOR END USERS
  • FIGURE 35 KEY BUYING CRITERIA FOR MAJOR END USERS
  • FIGURE 36 JURISDICTION AND TOP APPLICANT ANALYSIS IN VNA & PACS MARKET, JANUARY 2022–MAY 2025
  • FIGURE 37 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR VNA & PACS SOLUTIONS (JANUARY 2015–MAY 2025)
  • FIGURE 38 NORTH AMERICA: VNA & PACS MARKET SNAPSHOT
  • FIGURE 39 UK: NUMBER OF MEDICAL IMAGING UNDER NATIONAL HEALTH SERVICE (NHS), JANUARY 2022–JANUARY 2023
  • FIGURE 40 ASIA PACIFIC: VNA & PACS MARKET SNAPSHOT
  • FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET, 2020–2024 (USD MILLION)
  • FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VNA & PACS MARKET (2024)
  • FIGURE 43 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 44 VNA & PACS MARKET: COMPANY FOOTPRINT
  • FIGURE 45 VNA & PACS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 46 EV/EBITDA OF KEY VENDORS
  • FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF VNA AND PACS VENDORS
  • FIGURE 48 VNA & PACS MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • FIGURE 49 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT
  • FIGURE 50 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 SECTRA AB: COMPANY SNAPSHOT
  • FIGURE 52 GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 54 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 55 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT

 

The study involved five major activities to estimate the current size of the vendor-neutral archive (VNA) & picture archiving and communication systems (PACS) market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

This research study used secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing VNA & PACS solutions is assessed using secondary data from paid and free sources; this involves analyzing the product portfolios of major players and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

The secondary research process involved referring to various secondary sources to identify and collect information related to the study. These sources included annual reports, press releases, investor presentations of VNA and PACS vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information and assess prospects.

Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies adopted by key players.

After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of VNA and PACS solutions offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

Breakdown of Primary Respondents:

Vendor Neutral Archive (VNA) & PACS Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Tiers are defined based on a company’s total revenue, as of 2022: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through the bottom-up approach (revenue share analysis) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, modality, deployment, vendor type, application, end user, and region).

Vendor Neutral Archive (VNA) & PACS Market

Data Triangulation

After arriving at the overall market size, the market size estimation process splits the market into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides in the VNA & PACS market.

Market Definition

The VNA & PACS market encompasses advanced medical imaging technologies that deliver cost-effective storage solutions and streamlined access to multimodal imaging data. These systems are pivotal within the healthcare IT ecosystem, enabling efficient digitization, storage, retrieval, and sharing of medical imaging data across diverse platforms. By ensuring interoperability and secure management of imaging data, VNA and PACS facilitate improved clinical workflows and enhance collaboration among healthcare professionals.

Stakeholders

  • VNA & PACS  Vendors
  • Government Bodies
  • Healthcare Service Providers
  • Clinical/Physician Centers
  • Healthcare Professionals
  • Health IT service Providers
  • Healthcare Associations/Institutes
  • Ambulatory Care Centers
  • Venture Capitalists
  • Distributors And Resellers
  • Maintenance And Support Service Providers
  • Integration Service Providers
  • Healthcare Payers
  • Advocacy Groups
  • Data Security and Privacy Experts
  • Investors And Financial Institutions
  • Industry Associations and Trade Groups

Report Objectives

  • To define, describe, and forecast the global VNA & PACS market by product type, modality, deployment, vendor type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall VNA & PACS market
  • To assess the VNA & PACS market with regard to Porter’s Five Forces, regulatory landscape, value chain, ecosystem map, patent protection, and key stakeholder & buying criteria
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the VNA & PACS market with respect to five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • To profile the key players in the VNA & PACS market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments such as agreements, partnerships, acquisitions; expansions; product launches and enhancements; and R&D activities in the VNA & PACS market.

 

Previous Versions of this Report

Vendor Neutral Archive (VNA) & PACS Market by Product Type (Department, Multi-department, Multi-Site), Modality (CT, MRI, X-rays, Ultrasound, Mammo, PET), Application (Cardio, Onco, Neuro), End User (Hospital, ASC, Diag center) & Region - Global Forecast to 2029

Report Code HIT 2128
Published in May, 2024, By MarketsandMarkets™

Vendor Neutral Archive ( VNA ) & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018

Report Code HIT 2128
Published in Oct, 2013, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Vendor Neutral Archive (VNA) & PACS Market

DMCA.com Protection Status